Verinata is driven by a sole, extraordinary purpose – maternal and fetal health. Our initial focus is to develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities using our proprietary technologies. We aim to reduce the anxiety associated with today's multi-step process, the unacceptable false-positive rates, the non-specific and sometimes confusing results of current prenatal screening methods, as well as the risk of current invasive procedures. In support of national guidelines recommending first trimester aneuploidy risk assessment, we believe women who desire such an assessment should be offered a single blood draw test with a definitive result. Verinata is conducting a prospective, blinded pivotal study to clinically validate the sensitivity and specificity of its first prenatal test on a large scale with results of the study expected in 2011.

LifeCodexx AG, part of Eurofins Scientific SE, is a German company located in Konstanz. The firm develops clinically validated molecular diagnostics.

Roche Diagnostics GmbH, part of Roche Holding AG, is a company headquartered in Mannheim, Germany, involved in laboratory analytical instruments. Andreas Schmitz and Claus Haberda are the current co-CEOs of the firm. On January 01, 1999 Roche Holding AG acquired Roche Diagnostics GmbH.

Yourgene Health Plc engages in the development and commercialization of genomic services and technologies. It primarily manufactures molecular diagnostic solutions for reproductive health, precision medicine and infectious diseases. It operates through the Genomic Technologies and Genomic Services segments. The Genomic Technologies segment represents the in vitro diagnostic products, software and instrumentation manufactured by the group. The Genomic Services segment operates testing laboratories in Taiwan and the UK, and provides services to clinicians, third party clinical service providers and contract research organizations. The company was founded on April 13, 2000 and is headquartered in Manchester, the United Kingdom.

Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital (founded in 1916) and New England Deaconess Hospital (founded in 1896). Among independent teaching hospitals, Beth Israel Deaconess Medical Center consistently ranks in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually. BIDMC researchers run more than 850 active sponsored projects and 200 clinical trials. The Harvard-Thorndike General Clinical Research Center, the oldest clinical research laboratory in the United States, has been located on this site since 1973.

TDL Genetics Ltd., a subsidiary of Sonic Healthcare Ltd., is a company headquartered in London, UK. The firm specializes in testing, diagnosis and genetic counseling of inherited disorders.\nThe company says this about itself: TDL Genetics is a consultant-led service which is able to provide extensive expertise in the testing, diagnosis and genetic counselling of inherited disorders. Genetic tests are performed on DNA for molecular genetic analysis and on whole chromosomes for cytogenetic analysis. Some tests are part of profiles that can be linked with assays from other TDL disciplines, such as biochemistry and haematology. Genetic testing is sometimes complex and tests will vary in their ability to detect mutations or to detect all patients who have, or will develop, the disease. Some tests are diagnostic for a condition, others are indicative or are associated with an altered risk for a condition. Results can affect the lives of individuals and have implications for their family, for insurance and employment. Where testing will predict the inheritance of a disease in a healthy person, counselling and consent are mandatory. For these tests, please complete the Genetic Request form at the back of the laboratory guide (including informed consent). Our service provides result interpretation and risk assessment to patients and their family members.

BlueGnome Ltd. provides application software services. It offers solutions for detection of copy number variation in the human genome. The firm's main application areas include analysis of constitutional samples to elucidate genetic disease, investigation of haematological malignancies and aneuploidy screening of single cells. The company was founded on October 15, 2001 and is headquartered in Saffron Walden, the United Kingdom.

Cell Line Genetics (CLG) is a leading provider of multi-species characterization services and products for the Stem Cell, Cancer and Cell Therapy Research Market. Our clients include prestigious academic and research institutes as well as biotechnology and pharmaceutical companies. Our services include g-band, FISH and molecular (aCGH) cytogenetics, cell authentication and screening and custom assay development. CLG also sells high-sensitivity FISH probes tailored for Stem Cell and Gene-specific applications.

Enumera Molecular is a life science tools company headquartered in Ann Arbor, MI, developing a scalable biomolecule assessment platform enabling lower-cost, rapid clinical liquid biopsy tests. It helps in transforming the field of clinical molecular testing into a simpler, more actionable tool for physicians to benefit patient care.

The BTG Specialty Pharmaceuticals business develops, manufactures and commercializes life-saving antidotes used in hospitals and emergency care settings, including the clinically proven and leading products CroFab®, DigiFab®, and Voraxaze®.

They contribute to people's living and health byapplying innovative chromosome engineeringtechnology developed by Tottori University (Japan) to medical treatment and drug discovering widely

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

AusHealth Corporate Pty Ltd. develops pharmaceutical products. It offers industry health services, including onsite, laboratory, drug, alcohol testing products and services, such as alcohol breathalyzers, urine, saliva drug testing kits and tongue wipe drug testing machines, as well as policy development, drug testing sample collection and result analysis and dissemination services. The firm also provides pathology testing services, such as employee and executive health, heavy metals, drug and alcohol, bowel cancer, and insurance screening, as well as clinical trials. The company was founded in 1985 and is headquartered in Adelaide, Australia.

Part of MOH Holdings Pte Ltd., Singapore Health Services Pte Ltd. is a Singaporean company located in Singapore. The firm provides medical services. Ivy Ng is the CEO, in this role since 2012.

Monaliza Medical Ltd. develops a genetic test platform enabling prenatal genetic screening in Transcervical Cell samples taken in the first trimester of pregnancy. It develops non-invasive prenatal screening and diagnostic tests for early detection of fetal abnormalities. The company was founded in 2004 and is headquartered in Ra'anana, Israel

Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.

Clonatec SA is a French private company located in Paris. The firm manufactures diagnostic kits.

Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France.

Hangzhou Bosheng Biotechnology Co. Ltd. is a Chinese private company located in Hangzhou. The firm distributes medical equipments.

Wuxi Zhongde Meilian Biotechnology Co., Ltd., established on 2006-12-05, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Production of formula food for special medical purpose;Inspection and testing service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Research and development of bio-based materials technology;Manufacturing of bio-based materials;Development of Human Gene Diagnosis and Therapy Technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Specialty Chemicals Sales(Free of Hazardous Chemicals);rental service(Licensed rental services not included);Import and export;Technology Import and Export;Conference and Exhibition Services;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Information Technology Consulting Services;Labor service(Does not include labor dispatch)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)